View

May 13, 2024, 04:05 AM by Margaret Fontana

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Biosimilars Special Interest Group highlighting the need for clearer guidance on when and how to conduct health technology assessments (HTAs) for biosimilars.

Apr 23, 2024, 04:05 AM by B Lane

ISPOR announced the sessions and speakers for its Patient-Centered Research Summit 2024. The Summit is scheduled to be held May 5 in Atlanta, GA, USA and is co-located with the Society’s annual international conference, ISPOR 2024.

Apr 22, 2024, 04:05 AM by B Lane

ISPOR announced the plenary sessions and speakers for ISPOR 2024, its annual international conference and the leading global conference for health economics and outcomes research (HEOR). ISPOR 2024 will be held May 5-8 in Atlanta, GA, USA.

Apr 9, 2024, 04:05 AM by Margaret Fontana

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

Apr 2, 2024, 04:05 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced that it has launched a new microsite that provides HEOR information and resources organized by topical areas of interest—HEOR by Topic.

Feb 26, 2024, 04:05 AM by Margaret Fontana

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Jan 29, 2024, 04:05 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced that it has launched its new online learning platform for HEOR education and training—ISPOR Education Center.

Jan 23, 2024, 04:05 AM by Margaret Fontana

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Jan 22, 2024, 04:05 AM by B Lane

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

Jan 16, 2024, 04:00 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced the publication of its “2024-2025 Top 10 HEOR Trends Report.” The Society publishes this report as part of its horizon scanning and monitoring of the trends that affect healthcare decision making around the world.

Dec 18, 2023, 00:00 AM by B Lane

ISPOR announced the appointment of Nancy J. Devlin, PhD, University of Melbourne, Australia as an editor-in-chief for Value in Health.

Dec 11, 2023, 04:05 AM by B Lane

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer.

Dec 5, 2023, 04:05 AM by B Lane

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Nov 7, 2023, 04:05 AM by B Lane

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.

Nov 6, 2023, 04:05 AM by B Lane

Value in Health, the official journal of ISPOR, announced the publication of the results of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions

Oct 3, 2023, 04:05 AM by B Lane

ISPOR announced the recipients of its 2023 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

Sep 25, 2023, 04:05 AM by Betsy Lane

ISPOR announced the plenary sessions and speakers for ISPOR Europe 2023. The conference is scheduled for 12-15 November in Copenhagen, Denmark with the theme, “Health Economics and Outcomes Research at the Nexus of Policy and Science.”

Sep 5, 2023, 04:05 AM by Betsy Lane

Value in Health, the official journal of ISPOR, announced the publication of a report that identifies expensive Medicare Part B drugs with low added therapeutic benefit and models a reimbursement policy for them based on domestic reference pricing.

Aug 28, 2023, 04:05 AM by Betsy Lane

ISPOR announced that Laura Pizzi, PharmD, MPH will be assuming the role of Chief Science Officer at the Society. ISPOR’s previous Chief Science Officer, Richard J. Willke, PhD, will be retiring.

Aug 15, 2023, 04:05 AM by Betsy Lane

Value in Health published a new ISPOR Report that provides an overview of gaps and challenges in the value assessment of biosimilars and identifying potential approaches to address them. The report was published in the August 2023 issue of Value in Health.